Medicare Enrolled
Dr. Brook Brouha, MD/PHD
Dermatopathology Physician · La Jolla, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Brouha from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Brouha?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Brouha
Dr. Brook Brouha is a dermatopathology physician in La Jolla, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Brouha performed 12,369 Medicare services across 2,718 unique beneficiaries.
Between the years covered by Open Payments, Dr. Brouha received a total of $17,346 from 39 pharmaceutical and/or device companies across 787 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatopathology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Brouha is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 12% volume in CA
$17,346 industry payments
Medicare Practice Summary
Medicare Utilization ↗12,369
Medicare services
Top 12% in CA for dermatopathology physician
2,718
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~728 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Photodynamic therapy gel for precancerous skin | 6,800 | $1 | $3 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
2,091 | $6 | $35 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
759 | $97 | $191 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
725 | $65 | $129 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
722 | $43 | $149 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
361 | $93 | $187 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
218 | $1 | $3 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
167 | $74 | $177 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
114 | $41 | $78 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
69 | $79 | $193 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
58 | $123 | $296 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
53 | $12 | $44 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
41 | $38 | $103 |
| Light therapy to destroy precancerous skin growth This procedure uses light to treat and remove precancerous skin lesions. It is a method for destroying abnormal skin cells before they become cancerous. |
36 | $128 | $238 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
28 | $45 | $95 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
26 | $151 | $460 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
26 | $137 | $322 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
19 | $108 | $222 |
| Skin growth shaving, 0.5 cm or less This procedure involves shaving off a small skin growth measuring 0.5 centimeters or less from the body, arms, or legs. |
18 | $73 | $128 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters. |
14 | $109 | $265 |
| Destruction of cancer skin growth on trunk, arms, or legs, 0.5 cm or less This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that is 0.5 centimeters or smaller in size. |
12 | $66 | $174 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
12 | $57 | $133 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$17,346
Total received (2018-2024)
Avg $2,478/year across 7 years
Top 5% in CA for dermatopathology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
787
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,941 (86.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,405 (13.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,578
2023
$5,662
2022
$2,258
2021
$1,753
2020
$1,100
2019
$1,827
2018
$1,168
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$498
Janssen Biotech, Inc.
$399
Incyte Corporation
$378
PFIZER INC.
$335
SUN PHARMACEUTICAL INDUSTRIES INC.
$286
Lilly USA, LLC
$257
Galderma Laboratories, L.P.
$189
Novartis Pharmaceuticals Corporation
$175
Arcutis Biotherapeutics, Inc.
$166
LEO Pharma Inc.
$151
Amgen Inc.
$131
Regeneron Healthcare Solutions, Inc.
$131
GENZYME CORPORATION
$87
UCB, Inc.
$67
Boehringer Ingelheim Pharmaceuticals, Inc.
$63
Dermavant Sciences, Inc.
$56
Genentech USA, Inc.
$41
E.R. Squibb & Sons, L.L.C.
$36
STRATA Skin Sciences, Inc.
$28
Almirall LLC
$25
Biofrontera Inc.
$23
Kyowa Kirin, Inc.
$22
Helsinn Therapeutics (U.S.), Inc.
$19
Verrica Pharmaceuticals Inc.
$13
Top 3 companies account for 35.6% of 2024 payments
All-time payments by company (2018-2024) ›
Arcutis Biotherapeutics, Inc.
$2,571
PFIZER INC.
$1,396
Janssen Biotech, Inc.
$1,167
Lilly USA, LLC
$1,132
Regeneron Healthcare Solutions, Inc.
$1,080
ABBVIE INC.
$1,036
Incyte Corporation
$927
AbbVie Inc.
$893
Sun Pharmaceutical Industries Inc.
$887
GENZYME CORPORATION
$744
LEO Pharma Inc.
$714
Novartis Pharmaceuticals Corporation
$671
UCB, Inc.
$445
SUN PHARMACEUTICAL INDUSTRIES INC.
$408
Galderma Laboratories, L.P.
$363
AbbVie, Inc.
$351
Amgen Inc.
$326
SANOFI-AVENTIS U.S. LLC
$235
Almirall LLC
$232
DERMIRA, INC.
$206
Biofrontera Inc.
$169
Dermavant Sciences, Inc.
$159
Ortho Dermatologics, a division of Bausch Health US, LLC
$157
Celgene Corporation
$126
Genentech USA, Inc.
$124
STRATA Skin Sciences, Inc.
$106
Tactile Systems Technology Inc
$98
Allergan Inc.
$96
Boehringer Ingelheim Pharmaceuticals, Inc.
$92
Stemline Therapeutics Inc.
$82
E.R. Squibb & Sons, L.L.C.
$63
Merck Sharp & Dohme Corporation
$57
Kyowa Kirin, Inc.
$46
DUSA Pharmaceuticals, Inc.
$46
Journey Medical Corporation
$39
VYNE Pharmaceuticals Inc.
$37
Verrica Pharmaceuticals Inc.
$35
Helsinn Therapeutics (U.S.), Inc.
$19
Sensus Healthcare, Inc.
$10
Top 3 companies account for 29.6% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · Ameluz · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · BOTOX COSMETIC · Bimzelx · CIBINQO · COSENTYX · Cimzia · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dermatological Psoriasis and Vitiligo Treatment · EBGLYSS · ELZONRIS · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Erivedge · FLEXITOUCH · Flexitouch Plus · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · JUBLIA · Klisyri · LEVULAN KERASTICK · LIBTAYO · NO PRODUCT DISCUSSED · ODOMZO (sonidegib) capsules · OLUMIANT · OPZELURA · Odomzo · Otezla · POTELIGEO · Poteligeo · QBREXZA · REMICADE · RETIN-A-MICRO · RINVOQ · SILIQ · SIVEXTRO · SKYRIZI · SPEVIGO · Seysara · Skyrizi · Sotyktu · TALTZ · TREMFYA · Tremfya · VALCHLOR · VTAMA · Winlevi · XELJANZ · XOLAIR · XTRAC · Xolair · YCANTH · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for dermatopathology physician in CA.
Geographic Context
Dermatopathology physicians within 10 mi
13
Per 100K population
0.4
County median income
$102,285
Nearest hospital
SCRIPPS MEMORIAL HOSPITAL LA JOLLA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Brouha is a mixed practice specialist, with above-average Medicare volume (top 12% in CA), with low-engagement industry engagement in the top 5% of CA peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Brouha experienced with photodynamic therapy gel for precancerous skin?
Based on Medicare claims data, Dr. Brouha performed 6,800 photodynamic therapy gel for precancerous skin services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Brouha receive payments from pharmaceutical companies?
Yes. Dr. Brouha received a total of $17,346 from 39 companies across 787 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Brouha's costs compare to other dermatopathology physicians in La Jolla?
Dr. Brouha's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Brouha) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatopathology Physicians in La Jolla
Browse dermatopathology physicians in La Jolla ranked by procedure volume and transparency data.
Highest volume
Top Dermatopathology Physicians in CA
Dermatopathology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatopathology Physicians in CA
Which CA dermatopathology physicians receive the most from drug and device companies.
By company
Arcutis Biotherapeutics, Inc. Payments to Doctors
See all physicians who received payments from Arcutis Biotherapeutics, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology